Mallinckrodt Hospital Products IP Limited et al v. Baxter Healthcare Corporation
| Mallinckrodt Hospital Products Inc., New Pharmatop L.P. and Mallinckrodt Hospital Products IP Limited |
| Baxter Healthcare Corporation |
| 1:2020cv00434 |
| March 27, 2020 |
| US District Court for the District of Delaware |
| Leonard P Stark |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 1 |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on April 30, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 11
Consent Judgment and Order of Permanent Injunction, ***Civil Case Terminated. Signed by Judge Leonard P. Stark on 4/28/20. (ntl)
|
| Filing 10 PROPOSED CONSENT JUDGMENT and Order of Permanent Injunction by Mallinckrodt Hospital Products IP Limited, Mallinckrodt Hospital Products Inc., New Pharmatop L.P.. (Tigan, Jeremy) |
|
SO ORDERED, re #9 STIPULATION TO EXTEND TIME to answer, move or otherwise respond to Plaintiffs' Complaint to July 20, 2020 filed by Baxter Healthcare Corporation. Signed by Judge Leonard P. Stark on 4/2/20. (ntl)
|
| Filing 9 STIPULATION TO EXTEND TIME to answer, move or otherwise respond to Plaintiffs' Complaint to July 20, 2020 - filed by Baxter Healthcare Corporation. (Rovner, Philip) |
| Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
| Filing 8 SUMMONS Returned Executed by Mallinckrodt Hospital Products Inc., Mallinckrodt Hospital Products IP Limited, New Pharmatop L.P.. Baxter Healthcare Corporation served on 3/30/2020, answer due 4/20/2020. (Tigan, Jeremy) |
| Filing 7 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by New Pharmatop L.P.. (lak) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Mallinckrodt plc. for Mallinckrodt Hospital Products Inc. filed by Mallinckrodt Hospital Products Inc. (lak) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Mallinckrodt plc. for Mallinckrodt Hospital Products IP Limited filed by Mallinckrodt Hospital Products IP Limited. (lak) |
| Filing 4 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 2/20/2020. Date of Expiration of Patent: see attached.Thirty Month Stay Deadline: 8/20/2028. (lak) |
| Filing 3 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,992,218 B2 ;9,399,012 B2 ;9,610,265 B2 ;9,987,238 B2 ;10,383,834 B2. (lak) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lak) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT - filed with Jury Demand against Baxter Healthcare Corporation - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2887345.) - filed by Mallinckrodt Hospital Products Inc., Mallinckrodt Hospital Products IP Limited, New Pharmatop L.P.. (Attachments: #1 Exhibit A-F, #2 Civil Cover Sheet) (lak) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
